CEMIP and breast carcinoma: Several studies described that CEMIP was highly expressed in invasive breast cancer specimens and in invasive MDA-MB-231 TNBC cell lines, whereas some researchers observed much lower expression of CEMIP in non-invasive BC cells with a low-invasive potential, like MCF-7, T-47D, and ZR-75-1 cell lines (Evensen et al., 2013; Zhang et al., 2014).